Harshitha Dudipala, MD
@HersheyDudipala
Followers
140
Following
119
Media
14
Statuses
50
UCSD Heme/Onc Fellow @UCSDCancer ☀️ | Residency @BMCimRES | @NEOMEDedu alum | Mental Health Advocate | #WomeninMedicine | Polaroid Photography Enthusiast 📸
San Diego, CA
Joined June 2023
Always on top! Congrats @DrRanaMcKay !.
We’re proud to present the KidneyCAN Catalyst Award to Dr. Rana McKay of UC San Diego. Dr. McKay is a leader whose work has helped move the field of kidney cancer forward through groundbreaking research, clinical collaboration, and a deep commitment to patients and advocacy. Her
0
0
0
RT @HemUcsd: Say hello to our official UCSD Heme/Onc Fellows of 2025-2026! Ready to prescribe chemo at a cancer center near you 😎💉💊 https:/….
0
1
0
RT @DrRanaMcKay: I hope you will join me for the FORCE Ask the Experts webinar on hereditary prostate cancer on June 25, at 6:00 PM ET. Thi….
app.sosha.ai
0
5
0
RT @DrRanaMcKay: Largest molecular analysis to date of IDC-P. Associated with distinct DNA gene alterations and signatures scores. @Hershe….
0
1
0
RT @oncodaily: Highlights From Day 2 of ASCOGU25.@TiansterZhang @drenriquegrande @DocMattCampbell @shilpaonc @chavarriagaj @SuyogCancer @AS….
0
7
0
RT @DrRanaMcKay: Absolutely love the M3 (McKay Monthly Meeting) research group! Watch out for these amazing rising stars! @Jani_Chinmay @….
0
8
0
Awesome #ResearchToPractice Symposium regarding management of RCC by panelists @DrRanaMcKay @TiansterZhang @DrTHut and moderator @montypal — review of IO and TKI in ccRCC, optimal treatment of relapsed/refractory RCC, and role of HIF-2a inhibitors in VHL-associated RCC #GU25
1
4
20
RT @HemUcsd: First year fellow, @HersheyDudipala, and her mentor, @DrRanaMcKay, are shining at GU ASCO this week! Congratulations on your a….
0
1
0
Thanks so much @DrRanaMcKay for all your guidance with this project! Was excited to present! #GU25 @UCSDCancer.
Great to see our amazing fellow @HersheyDudipala presenting data on our molecular profiling of intraductal prostate cancer at #GU25! Associated with NEPC signature, DLL3 expression and worse molecular features. @UCSDCancer
0
0
6
What an awesome talk by @OncBrothers on the Advancements in Thoracic Oncology at #WCLC24. Great to hear from some amazing panelists @Latinamd @NarjustFlorezMD @DrJNaidoo @CharuAggarwalMD @RManochakian @lungoncdoc
1
3
25
RT @HemUcsd: Happy first Friday conference to our new fellows! Thanks to Dr. @ErinReidMD for teaching us marrows after Dr. Heyman’s lecture….
0
3
0
Wanted to share an interesting case of a neuroendocrine tumor that transformed from secreting one type of peptide hormone to another!.@BMCimRES.
0
0
3
Graduated from internal medicine residency at Boston University Medical Center! It’s been an amazing 3 years, and I couldn’t have asked for a better place to complete my training. Thank you @BMCimRES for helping me get one step closer to my dreams. @UCSDCancer here I come :)
9
2
93
Check out our new review article regarding incidence, pathogenesis, and management of non-clear cell renal cell carcinoma! Thank you @DrRanaMcKay for all your guidance! @UCSDCancer
journals.sagepub.com
Renal cell carcinoma (RCC) is the most common type of kidney cancer and is divided into two distinct subtypes, clear cell renal cell carcinoma (ccRCC) and non-c...
0
0
7